Bone and soft tissue tumors, cysts, and cancers (sarcoma)
Complex joint reconstruction
Rare bone diseases
Biopsy and excision of all benign and malignant tumors of the bones and soft tissue
Complex bone and joint reconstruction including bone transplantation and custom prosthetic reconstructions of the extremities and spine
Please call our office if you have questions regarding your insurance coverage. If you have out of network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.
Attending Orthopaedic Surgeon, Hospital for Special Surgery
Professor of Orthopaedic Surgery, Weill Cornell Medical College
Attending Orthopedic Surgeon, NewYork-Presbyterian Hospital
Memorial Sloan-Kettering Cancer Center
President, Musculoskeletal Tumor Society, 2013-2014
President, Association of Bone Joint Surgeons, 2010-2011
President, International Society of Limb Salvage, 1997-1999
International Skeletal Society
Orthopaedic Research Society
Orthopaedic Surgery 1987, 1997, 2007, 2018
Castle Connolly America's Top Doctors, 2002-2020
Castle Connolly Top Doctors in New York Metro Area, 2002-2021
New York Magazine Top Doctors, 2002-2021
Castle Connolly America's Top Doctors for Cancer, 2006-2020
Philip D. Wilson, Jr., M.D. Award for Teaching Excellence Weill Cornell Medical College, 1989, 1997, 2004
Kashiwagi-Sumihara Japan - United States Exchange Traveling Fellowship, 1992
Clinical Oncology Career Development Award, American Cancer Society, 1988-1990
Zimmer Award for Orthopaedic Research, Orthopaedic Research and Education Foundation, 1985-1987
Alpha Omega Alpha Medical Honor Society, University of Vermont, 1978
MD, University of Vermont
BS, Yale University
Tufts New England Medical Center, Boston, MA
Hospital for Special Surgery, Orthopaedic Surgery, New York
Memorial Sloan-Kettering Cancer Center, Orthopaedic Oncology, New York
Hospital for Special Surgery, Orthopaedic and Biochemistry Research
Deputy Editor, Clinical Orthopaedics and Related Research, Musculoskeletal Tumor Society and International Society of Limb Salvage
Hoshino, A., Costa-Silva, B., Shen, T.-L., Healey, J (...), Bromberg, J., Lyden, D. Tumour exosome integrins determine organotropic metastasis. (2015) Nature 527(7578), pp. 329-335
Meyers, P.A., Heller, G., Healey, J., (...), Vlamis, V., Rosen, G. Chemotherapy for nonmetastatic osteogenic sarcoma: The Memorial Sloan-Kettering experience. (1982) Journal of Clinical Oncology 10(1), pp. 5-15
Kawai, A., Woodruff, J., Healey, J.H., (...), Antonescu, C.R., Ladanyi, M. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. (1998) New England Journal of Medicine 338(3), pp. 153-160
Meyers, P.A., Schwartz, C.L., Krailo, M., Healey J. (...), Womer, R., Grier, H. Osteosarcoma: A randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. (2008) Journal of Clinical Oncology 26(4), pp. 633-638
De Alava, E., Kawai, A., Healey, J.H., (...), Barr, F.G., Ladanyi, M. EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. (1998) Journal of Clinical Oncology 16(4), pp. 1248-1255
Kawai, A., Muschler, G.F., Lane, J.M., Otis, J.C., Healey, J.H. Prosthetic knee replacement after resection of a malignant tumor of the distal part of the femur: Medium to long-term results. Journal of Bone and Joint Surgery - Series A 80(5), pp. 636-647
Healey, J.H., Zimmerman, P.A., McDonnell, J.M., Lane, J.M. Percutaneous bone marrow grafting of delayed union and nonunion in cancer patients. (1990) Clinical Orthopaedics and Related Research
(256), pp. 280-285
Tap, W.D., Wainberg, Z.A., Anthony, S.P., Healey J. (...), Tong-Starksen, S., Bollag, G. Structure-guided blockade of CSF1R kinase in tenosynovial giant-cell tumor. (2015) New England Journal of Medicine
373(5), pp. 428-437
Marco, R.A., Gitelis, S., Brebach, G.T., Healey, J.H.. Cartilage tumors: evaluation and treatment. (2000) The Journal of the American Academy of Orthopaedic Surgeons 8(5), pp. 292-304
Healey, J.H., Morris, C.D., Athanasian, E.A., Boland, P.J. Compress® knee arthroplasty has 80% 10-year survivorship and novel forms of bone failure. (2013) Clinical Orthopaedics and Related Research 471(3), pp. 774-783
Debnath, S., Yallowitz, A.R., McCormick, J., Healey J, (...), Landau, D.A., Greenblatt, M.B. Discovery of a periosteal stem cell mediating intramembranous bone formation. (2018) Nature 562(7725), pp. 133-139
For more publications, please see the PubMed listing.
Randomized trial of colchicine to enhance range of motion after knee manipulation
Randomized trial to enhance function after surgery for subtrochanteric metastatic cancer.
Parity: Randomized trial of antibiotic regimens for megaprosthetic replacements after tumor surgery
Fluorescent screening of tumor bed to reduce recurrence after extremity sarcoma surgery
One of the goals of HSS is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.
As part of the disclosure process, this website lists physician collaborations with outside companies. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.
Below are the healthcare industry relationships reported by Dr. Healey as of January 20, 2020.
By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.
Patients should feel free to ask their HSS physicians questions about these relationships.